Glutathione (GSH) is the most abundant endogenous antioxidant in the human body — a tripeptide (Gamma-Glu-Cys-Gly) that exists in virtually every cell and serves as the master redox buffer, detoxification substrate, and immune regulatory molecule of cellular biology. Injectable glutathione bypasses the oral bioavailability limitation that makes oral supplementation largely ineffective: glutathione is cleaved by intestinal peptidases before absorption, delivering cysteine for resynthesis rather than intact glutathione. Intravenous or subcutaneous injection of reduced glutathione (GSH) delivers the intact tripeptide directly to circulation and tissue, achieving cellular glutathione repletion impossible through oral routes.

The biological functions of glutathione span the breadth of cellular physiology. As a direct antioxidant, GSH neutralizes hydrogen peroxide, lipid hydroperoxides, and reactive nitrogen species through glutathione peroxidase-catalyzed reactions — regenerating to its oxidized form (GSSG) and then back to GSH by glutathione reductase using NADPH. As a detoxification substrate, glutathione-S-transferases conjugate GSH to electrophilic compounds (environmental toxins, drug metabolites, carcinogens) for urinary or biliary excretion — phase II hepatic detoxification depends fundamentally on adequate glutathione supply. As a protein redox regulator, glutathione maintains critical protein thiols in reduced (active) form, protecting enzymes and structural proteins from oxidative inactivation.

Injectable glutathione has well-documented clinical applications beyond supplementation. In acetaminophen (Tylenol) overdose, IV N-acetylcysteine (a GSH precursor) is the standard antidote precisely because APAP toxicity depletes hepatic glutathione, causing oxidative liver damage — replacing glutathione reverses the toxicity mechanism. In Parkinson's disease, IV glutathione showed improvements in motor function in small clinical trials, attributed to its antioxidant protection of dopaminergic neurons against oxidative stress. Skin-lightening applications of injectable glutathione exploit its inhibition of tyrosinase (the rate-limiting enzyme in melanin synthesis) — high-dose GSH reduces melanin production and produces a gradual, even complexion brightening.

The immune regulatory functions of glutathione are substantial: lymphocyte proliferation and NK cell cytotoxicity both depend on adequate intracellular GSH levels. T-cells with depleted glutathione show impaired proliferative responses and reduced IL-2 production — making glutathione repletion directly immunostimulatory in states of oxidative depletion (illness, intense exercise, aging, HIV). GSH levels decline significantly with age and under chronic stress, making injectable repletion relevant for aging populations and high-stress contexts.

The 200mg vial is the entry-level dose — appropriate for first-time users, sensitive individuals, or as a component of a larger IV protocol where glutathione is one of multiple infused compounds. Standard IV push doses in clinical practice range from 600mg to 1500mg; the 200mg dose is better suited for subcutaneous administration or as a low-dose IV bolus.